Project Grant R43AR083320
Award Date
9/1/23
Completion Date
8/31/24
Dollars Obligated
$300K
Awardee
Collamedix Inc. (GS4LCAYKAVC7)
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
This federal Project Grant award of $300,000 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports the development and validation of Collamedix Inc.'s ALLOBRACE device. ALLOBRACE is a pure collagen sheath designed to enhance the biological integration and performance of soft tissue allografts used in anterior cruciate ligament (ACL) reconstruction surgery. The...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) totals $549,437 and supports research to improve tendon-to-bone integration after anterior cruciate ligament (ACL) reconstruction surgery. The primary awardee, The Trustees of the University of Pennsylvania, will locally deliver a small molecule Hedgehog signaling agonist to stimulate the formation...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Panorama Research Incorporated, doing business as Panorama Research Inc., a $275,765 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to develop an antibody-based therapy for reducing scarring and fibrosis following joint surgeries. The project aims to improve the delivery and tissue residence of a lead humanized antibody that inhibits collagen fibril formation, thereby...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $680,325 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the Massachusetts Institute of Technology (MIT) to conduct research on collagen proteostasis. The grant aims to elucidate the critical mechanisms of intracellular collagen folding and quality control, and assess the therapeutic potential of proteostasis network-targeted interventions for collagenopathies -...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $660,000 to Duke University to conduct research investigating in vivo anterior cruciate ligament (ACL) mechanics and risk factors for non-contact ACL injury. The research aims to utilize a novel multimodal imaging methodology to assess the impact of knee kinematics and morphology...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Oregon a $360,580 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The project aims to develop a novel anisotropic, degradable poly(ethylene glycol) hydrogel-based engineered extracellular matrix (EECM) that can promote the alignment and regenerative characteristics of human tenocytes. Key activities include characterizing the material...
The University of California, Davis received a $600,475 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The purpose of this award is to develop a collagen-based scaffold modified with specific integrin ligands and extracellular vesicles derived from placental mesenchymal stem cells. This engineered scaffold is intended to recruit and guide...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $704,514 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to the University of Texas Health Science Center at Houston (UTHealth). The project aims to conduct a multi-center, longitudinal study comparing the effects of different surgical techniques for acromioclavicular (AC) joint reconstruction on shoulder biomechanics and soft tissue health....
The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $752,620 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The Washington University. The grant, awarded on September 20, 2024, with a completion date of August 31, 2026, will support the development of alginate hydrogels with tethered insulin-like growth factor 1 (IGF-1) mimetic peptides. These engineered hydrogels are designed to enhance the...
This $393,412 Project Grant was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), to Vanderbilt University on September 17, 2024. The goal of the project is to establish engineered, joint-resident cells as therapeutic agents to promote cartilage repair and mitigate inflammation in osteoarthritis. Key products and services to be delivered...